Trial Profile
A Double Blind (3rd Party Open), Randomised, Placebo-Controlled, Dose Escalation Study To Investigate The Safety, Toleration, And Pharmacokinetics Of Single Inhaled Doses Of Pf-05212372 In Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Nov 2012
Price :
$35
*
At a glance
- Drugs ZPL 5212372 (Primary)
- Indications Asthma
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 15 Aug 2011 New trial record